Table 1.
Demographic and Clinical Characteristics.
Variable | Patients with Major Depressive Disorder |
Healthy Subjects (N=91) | ||
---|---|---|---|---|
Medication-free (N=50) | Hypnotics (N=50) | Total (N=100) | ||
Age, years | 41.5 ± 12.9 | 44.2 ± 10.0 | 42.9 ± 10.7 | 42.1 ± 12.6 |
Gender, Male/Female | 23/37 | 14/36 | 37/63 | 34/57 |
Type of benzodiazepine used | ||||
Short-acting, N (%) | 32 (64) | 32 (32) | ||
Intermediate, N (%) | N/A | 25 (50) | 25 (25) | N/A |
Long-acting, N (%) | 24 (48) | 24 (24) | ||
Beck Depression Inventory | 20.7 ± 14.9* | 33.3 ± 14.1* | 27.2 ± 15.7* | 6.1 ± 6.6 |
Hamilton Depression Rating Scale, 17 items | 14.3 ± 8.1* | 16.8 ± 7.9* | 15.6 ± 8.1* | 1.7 ± 2.6 |
Pittsburgh Sleep Quality Index | 11.8 ± 4.0* | 14.0 ± 3.6* | 13.0 ± 4.0* | 4.7 ± 2.9 |
Epworth Sleepiness Scale | 9.1 ± 5.9 | 7.2 ± 6.5 | 8.1 ± 6.3 | 9.1 ± 5.1 |
Insomnia score derived from Beck Depression Inventory (item #16) | 1.5 ± 1.1* | 2.0 ± 0.9* | 1.8 ± 1.1* | 0.4 ± 0.7 |
Insomnia score derived from Hamilton Depression Rating Scale (item #4–6) | 3.0 ± 1.8* | 3.3 ± 2.0* | 3.1 ± 1.9* | 0.4 ± 0.8 |
N/A: not applicable.
Data represent mean ± 1 standard deviation unless otherwise noted.
Asterisk indicates statistical significance (p<0.05) compared with healthy controls.